Cargando…

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody

OBJECTIVE(S): Filamentous bacteriophage M13 was genetically engineered to specifically target mammalian cells for gene delivery purpose. MATERIALS AND METHODS: A vascular endothelial growth factor receptor 2 (VEGFR2)-specific nanobody was genetically fused to the capsid gene III of M13 bacteriophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ranjibar, Farideh, Habibi-Anbouhi, Mahdi, Kazemi-Lomedasht, Fatemeh, Aghaee-Bakhtiyari, Seyed Hamid, Alirahimi, Ehsan, Behdani, Mahdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272075/ https://www.ncbi.nlm.nih.gov/pubmed/30524687 http://dx.doi.org/10.22038/IJBMS.2018.26191.6432

Ejemplares similares

Expressing of Recombinant VEGFR2-specific Nanobody in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2021)

Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2018)

Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021)

Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021)

In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2017)

Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae
por: Akbari, Elaheh, et al.
Publicado: (2019)

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
por: Hosseininejad-Chafi, Mohammad, et al.
Publicado: (2022)

A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
por: Karami, Elmira, et al.
Publicado: (2020)

In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies
por: Mohseni, Nastaran, et al.
Publicado: (2020)

Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

In vitro evaluation of anti-angiogenesis property of anti-VEGFR2 nanobody-conjugated H40-PEG carrier loaded with methotrexate
por: Adyani, Seyed Masih, et al.
Publicado: (2022)

Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model
por: Salehi, Shima, et al.
Publicado: (2023)

A Model to Study the Phenotypic Changes of Insect Cell Transfection by Copepod Super Green Fluorescent Protein (cop-GFP) in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2016)

Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2
por: Behdani, Mahdi, et al.
Publicado: (2012)

Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123
por: Moradi-Kalbolandi, Shima, et al.
Publicado: (2016)

Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view
por: Najmeddin, Ali, et al.
Publicado: (2021)

Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate
por: Oghalaie, Akbar, et al.
Publicado: (2022)

Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
por: Kadkhodazadeh, Maryam, et al.
Publicado: (2022)

Development of polyclonal heavy chain antibodies targeting programmed death ligand-1
por: Oghalaie, Akbar, et al.
Publicado: (2023)

Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria
por: Shafiee, Fatemeh, et al.
Publicado: (2016)

Effectiveness of Plasmocure™ in Elimination of Mycoplasma Species from Contaminated Cell Cultures: A Comparative Study versus Other Antibiotics
por: Molla Kazemiha, Vahid, et al.
Publicado: (2019)

Systems biology and machine learning approaches identify drug targets in diabetic nephropathy
por: Abedi, Maryam, et al.
Publicado: (2021)

Direct Immobilization of Engineered Nanobodies on Gold Sensors
por: Simões, Bárbara, et al.
Publicado: (2021)

Antiadhesive and cytotoxic effect of Iranian Vipera lebetina snake venom on lung epithelial cancer cells
por: Oghalaie, Akbar, et al.
Publicado: (2017)

Evaluation of Factors Influencing Antibody Reduction for Development of Antibody Drug Conjugates
por: Abdollahpour-Alitappeh, Meghdad, et al.
Publicado: (2017)

Enhancement of keratinocyte growth factor potential in inducing adipose‐derived stem cells differentiation into keratinocytes by collagen‐targeting
por: Amidzadeh, Zahra, et al.
Publicado: (2022)

Incidental Synchronous (99m)Tc-HYNIC-TOC Avid Lesion of the Neck in a Patient with Metastatic Melanoma: A Metastatic Lymph Node or a Carotid Body Tumor Masquerading As a Lymph Node?
por: Roshanravan, Vahid, et al.
Publicado: (2022)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Pharyngeal Packing during Rhinoplasty: Advantages and Disadvantages
por: Razavi, Majid, et al.
Publicado: (2015)

In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins
por: Zareh-Khoshchehreh, Raziyeh, et al.
Publicado: (2023)

Engineering of Nanobodies Recognizing the Human Chemokine Receptor CCR7
por: Jakobs, Barbara D., et al.
Publicado: (2019)

Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
por: Chanier, Timothée, et al.
Publicado: (2019)

Exploiting sequence and stability information for directing nanobody stability engineering
por: Kunz, Patrick, et al.
Publicado: (2017)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

Genetic modification of cystic fibrosis with ΔF508 mutation of CFTR gene using the CRISPR system in peripheral blood mononuclear cells
por: Khatibi, Sepideh, et al.
Publicado: (2021)

Evaluation of the relationship between IL-12, IL-13 and TNF-α gene polymorphisms with the susceptibility to brucellosis: a case control study
por: Kazemi, Sima, et al.
Publicado: (2019)

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
por: Dabiri, Hamed, et al.
Publicado: (2023)

Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes
por: Banihashemi, Seyed Reza, et al.
Publicado: (2018)

Adrenaline-activated structure of the β(2)-adrenoceptor stabilized by an engineered nanobody
por: Ring, Aaron M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h3lh5lhm3fq7i7e2di12bc6q8u